Through these two genome-wide screens and integration with CRISPR knockout datasets from T cells, MED12, CCNC, and ARIH2 were identified as candidate genes whose knockout enhances the anti-tumor response of NK cells. This evidence concerns the gene CCNC and neoplasm.